>
Medartis Holding AG logo

MED - Medartis Holding AG Share Price

CHF69.7 0.2  0.3%

Last Trade - 14/04/21

Sector
Healthcare
Size
Mid Cap
Market Cap £646.6m
Enterprise Value £602.7m
Revenue £98.5m
Position in Universe 456th / 1046
Bullish
Bearish
Unlock MED Revenue
Momentum
Relative Strength (%)
1m +19.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -0.57%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
82.3 92.5 105 121.3 130.1 124.7 135.6 157.2 +8.7%
-54.4 -73.9 +435.7 -53.8 -91.7 +2,063 +97.0
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, MedartisHolding AG revenues decreased 4% to SF124.7M. Net lossapplicable to common stockholders totaled SF944K vs. incomeof SF2.1M. Revenues reflect LATAM segment decrease of 33%to SF9.7M, EMEA segment decrease of 3% to SF68.2M. Net lossreflects Foreign Exchange Losses increase from SF2.4M toSF5.4M (expense), Personnel Costs in Administrationincrease of 21% to SF10.5M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MED Revenue Unlock MED Revenue

Net Income

MED Net Income Unlock MED Revenue

Normalised EPS

MED Normalised EPS Unlock MED Revenue

PE Ratio Range

MED PE Ratio Range Unlock MED Revenue

Dividend Yield Range

MED Dividend Yield Range Unlock MED Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
MED EPS Forecasts Unlock MED Revenue
Profile Summary

Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 3, 1997
Public Since March 23, 2018
No. of Shareholders: n/a
No. of Employees: 636
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange SIX Swiss Exchange
Shares in Issue 11,778,148
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MED Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MED
Upcoming Events for MED
Frequently Asked Questions for Medartis Holding AG
What is the Medartis Holding AG share price?

As of 14/04/21, shares in Medartis Holding AG are trading at CHF69.7, giving the company a market capitalisation of £646.6m. This share price information is delayed by 15 minutes.

How has the Medartis Holding AG share price performed this year?

Shares in Medartis Holding AG are currently trading at CHF69.7 and the price has moved by 80.52% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medartis Holding AG price has moved by 41.06% over the past year.

What are the analyst and broker recommendations for Medartis Holding AG?

Of the analysts with advisory recommendations for Medartis Holding AG, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Medartis Holding AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Medartis Holding AG next release its financial results?

Medartis Holding AG is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Medartis Holding AG dividend yield?

Medartis Holding AG does not currently pay a dividend.

Does Medartis Holding AG pay a dividend?

Medartis Holding AG does not currently pay a dividend.

When does Medartis Holding AG next pay dividends?

Medartis Holding AG does not currently pay a dividend.

How do I buy Medartis Holding AG shares?

To buy shares in Medartis Holding AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medartis Holding AG?

Shares in Medartis Holding AG are currently trading at CHF69.7, giving the company a market capitalisation of £646.6m.

Where are Medartis Holding AG shares listed? Where are Medartis Holding AG shares listed?

Here are the trading details for Medartis Holding AG:

Country of listing: Switzerland
Exchange: SWX
Ticker Symbol: MED
What kind of share is Medartis Holding AG?

Based on an overall assessment of its quality, value and momentum, Medartis Holding AG is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Medartis Holding AG share price forecast 2021?

Shares in Medartis Holding AG are currently priced at CHF69.7. At that level they are trading at 19.42% premium to the analyst consensus target price of 0.00.

Analysts covering Medartis Holding AG currently have a consensus Earnings Per Share (EPS) forecast of 0.33 for the next financial year.

How can I tell whether the Medartis Holding AG share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medartis Holding AG. Over the past six months, the relative strength of its shares against the market has been 23.13%. At the current price of CHF69.7, shares in Medartis Holding AG are trading at 48.04% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medartis Holding AG PE Ratio?

The Medartis Holding AG PE ratio based on its reported earnings over the past 12 months is 4.55k. The shares are currently trading at CHF69.7.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medartis Holding AG?

Medartis Holding AG's management team is headed by:

Willi Miesch - DRC
Dominique Leutwyler - DCE
Axel Maltzen - MGB
H. C. Straumann - CHM
Dominik Ellenrieder - VCH
Juerg Greuter - DRC
Daniel Herren - DRC
Roland Hess - DRC
Damien Tappy - DRC
Christoph Broennimann - CEO
Anthony Durieux-Menage - CHO
Lisa Thompson - CEX
Mareike Loch - VPR
Manuel Schaer - CTO
Who are the major shareholders of Medartis Holding AG?

Here are the top five shareholders of Medartis Holding AG based on the size of their shareholding:

Straumann (Thomas) Individual Investor
Percentage owned: 47.77% (5.63m shares)
Ellenrieder (Dominik) Individual Investor
Percentage owned: 7.82% (921k shares)
Endeavour Medtech Growth, L.P. Corporation
Percentage owned: 6.61% (779k shares)
Miesch (Willi) Individual Investor
Percentage owned: 5.25% (618k shares)
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 2.99% (352k shares)
Similar to MED
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.